118 related articles for article (PubMed ID: 1472380)
61. Third Japanese Antisense Symposium, Kyoto, Japan. December 2 and 3, 1993.
Murakami A; Suzuki MM
Antisense Res Dev; 1994; 4(2):123-5. PubMed ID: 7950299
[No Abstract] [Full Text] [Related]
62. Why antisense technology makes good sense for cancer treatment.
Senior K
Pharm Sci Technol Today; 2000 Jul; 3(7):217-218. PubMed ID: 10884676
[No Abstract] [Full Text] [Related]
63. Editorial: Peptides Targeting Protein-Protein Interactions: Methods and Applications.
Belvisi L; D'Andrea LD; Jiménez MA
Front Mol Biosci; 2021; 8():780106. PubMed ID: 34722638
[No Abstract] [Full Text] [Related]
64. Sense, antisense, nonsense, and missense.
Cheng TO
Ann Thorac Surg; 1993 Aug; 56(2):397. PubMed ID: 8347040
[No Abstract] [Full Text] [Related]
65. Does antisense make sense?
Wallace RW
Drug Discov Today; 1999 Jan; 4(1):4-5. PubMed ID: 10234142
[No Abstract] [Full Text] [Related]
66. Why antisense could make sense for neurodegeneration.
Massey TH; Robertson NP
J Neurol; 2017 Jul; 264(7):1542-1544. PubMed ID: 28516330
[No Abstract] [Full Text] [Related]
67. Transcriptomics: Sense and antisense ability.
Burgess DJ
Nat Rev Genet; 2011 Jul; 12(8):519. PubMed ID: 21765453
[No Abstract] [Full Text] [Related]
68. Natural Antisense Makes Sense for Gene-specific Activation in Brain.
Varela MA; Roberts TC; Andaloussi SE; Wood MJ
Mol Ther Nucleic Acids; 2012 May; 1(5):e24. PubMed ID: 23344004
[No Abstract] [Full Text] [Related]
69. The sense of well-being: developing measures.
Glock CY
Science; 1976 Oct; 194(4260):52-4. PubMed ID: 17793072
[No Abstract] [Full Text] [Related]
70. THE SENSE OF EQUILIBRIUM.
F CL
Science; 1896 Apr; 3(69):625-6. PubMed ID: 17752116
[No Abstract] [Full Text] [Related]
71. THE SENSE OF SOLIDITY.
Dewey J
Science; 1898 Nov; 8(202):675. PubMed ID: 17744582
[No Abstract] [Full Text] [Related]
72. Making sense of it all.
Billingsley M
BMJ; 2016 Oct; 355():i4568. PubMed ID: 31055338
[No Abstract] [Full Text] [Related]
73. Making sense of the quality of evidence.
Wilkins KL
Can Oncol Nurs J; 2016; 26(1):68-69. PubMed ID: 31148735
[No Abstract] [Full Text] [Related]
74. Making commercial sense.
Johnson R
Nat Chem; 2022 May; 14(5):480-481. PubMed ID: 35513570
[No Abstract] [Full Text] [Related]
75. Making sense of missense.
Singh A
Nat Methods; 2023 Nov; 20(11):1622. PubMed ID: 37935983
[No Abstract] [Full Text] [Related]
76. A Sense of Discovery.
DiChristina M
Sci Am; 2018 Jul; 319(2):4. PubMed ID: 30020915
[No Abstract] [Full Text] [Related]
77. Antisense Peptide Technology for Diagnostic Tests and Bioengineering Research.
Štambuk N; Konjevoda P; Pavan J
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502016
[TBL] [Abstract][Full Text] [Related]
78. Targeting Tumor Markers with Antisense Peptides: An Example of Human Prostate Specific Antigen.
Štambuk N; Konjevoda P; Turčić P; Šošić H; Aralica G; Babić D; Seiwerth S; Kaštelan Ž; Kujundžić RN; Wardega P; Žutelija JB; Gračanin AG; Gabričević M
Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035335
[TBL] [Abstract][Full Text] [Related]
79. Structure-Based Reverse Vaccinology Failed in the Case of HIV Because it Disregarded Accepted Immunological Theory.
Van Regenmortel MH
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27657055
[TBL] [Abstract][Full Text] [Related]
80. Basic research in HIV vaccinology is hampered by reductionist thinking.
Van Regenmortel MH
Front Immunol; 2012; 3():194. PubMed ID: 22787464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
